Skip to main content

Ginger Pigott, Brent Sokol, and Miki Kolton to Speak at Fogarty Innovation

LOS ANGELES – Oct. 28, 2021 – Greenberg Traurig attorneys Ginger Pigott, Brent D. Sokol, and Eleanor “Miki” A. Kolton will present “Key Legal Considerations in MedTech Product Innovation” to early stage medical technology companies at Fogarty Innovation on Oct. 28, 2021 at 2 p.m. PDT.

Fogarty Innovation is a nonprofit educational incubator and accelerator for early stage medical technology companies and “global hub for novel thinking and creation.” Its mission is to create “a bold model for shaping the future of human health, guided by a focused, comprehensive vision.” Founded in 2012 by the renowned surgeon and inventor, Dr. Thomas Fogarty, dozens of companies have gone through the program and several have subsequently been acquired or planned IPOs. The presentation, which is co-sponsored by Greenberg Traurig, will discuss the path from ideation to the product market and the various regulatory, intellectual property, risk mitigation, and other hurdles along the way. As senior attorneys with decades of practice expertise, Pigott, Kolton, and Sokol have first-hand legal experience advising early stage and established companies who are working to advance new and innovative medical solutions and technologies.

Greenberg Traurig Shareholder Pigott provides critical product liability advice and litigation defense to emerging and established businesses. As a shareholder in the Pharmaceutical, Medical Device & Health Care Litigation Practice, she manages products liability litigation matters with an emphasis on the defense of complex medical device and pharmaceutical products. Pigott works with companies to reduce and eliminate litigation risk through essential assessment and review of potential product liability exposure, including helping to organize and establish more effective claims handling in pre-litigation as well as in identifying and reducing risk producing activities and providing information to allow companies to understand triggers for potential exposure and manage such risks.

Greenberg Traurig Shareholder Sokol has more than 25 years of experience representing medical device and biotechnology companies. He litigates complex intellectual property disputes, including those involving patent inventorship, ownership, licensing and infringement. As a former biomedical engineer and a registered patent attorney for over 25 years, Sokol is also an acknowledged leader and national speaker about the global corporate restructuring, sale, integration and licensing of multi-national intellectual property holdings.

Greenberg Traurig Of Counsel Kolton has wide-ranging legal, administrative, and management experience in medical practice law; HIPAA, Stark, Medicare and CMS regulations; with the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC); and other civil and administrative law areas. She possesses real-world executive corporate experience and broad clinical background in a variety of health care settings, including the ability to understand scientific and medical community cultures, business challenges and concerns.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Group: The Pharmaceutical, Medical Device & Health Care Litigation Group is an integral part of the firm’s 600+ attorney Litigation Practice. Led by “trial wizard” Lori G. Cohen, this team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include the shortlist for Benchmark Litigation’s 2020 “Product Liability Firm of the Year”; national rankings for 2019 “Product Liability & Mass Torts” from Chambers USA Guide; and national rankings for 2019 “Product Liability, Mass Tort and Class Action Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States.

About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.

About Greenberg Traurig: About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2300 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 25 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 4.0 Certified Plus. Web: